Transcatheter aortic valve replacement (TAVR) Market – Global Industry Analysis, Size, Share, Trends and Forecast, 2014

1. TRANSCATHETER AORTIC VALVE REPLACEMENT M TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET:TRENDS ANALYSI ARKET:TRENDS ANALYSIS AND FORECASTS UP TO 2022 S AND FORECASTS UP TO 2022 Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implanta- tion (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve’s place. Normally valve replacement method requires an open heart procedure with a ster- notomy, in which the chest is surgically separated for the treatment. Whereas, the TAVR procedures can be done through very small openings that leave all the chest bones in place. There are two methods available for TAVR surgical procedure, which in- cludes: (WHO), it has been estimated that the number of people suffering from cardiovascular diseases will increase to 22.2 million by 2030. The market for TAVR is expected to reach around USD 6.5 billion by 2022, growing at a CAGR of 21.3% during the fore- cast period of 2016e to 2022f. However, there are certain restraining factors which could hamper the growth of this market, which includes, high costs as- sociated with the LAVD implantation compared to other therapies available for CVD diseases. A TAVR device costs USD 30,000, which is six times the price of the average surgical valve. In addition, for a hospi- tal to be reimbursed for a TAVR procedure, the pa- tient must be evaluated by a multidisciplinary team that involves multiple cardiac surgeons and interven- tional cardiologists. However, there are some cost savings compared to surgery, such as shorter length of stay in the hospital.  Entering through the femoral artery (large artery in the groin), called the transfemoral approach, which does not require a surgical incision in the chest. or Geographically, North America is leading contributor to the market and is expected to retain its position during the forecast period. Nonetheless, the market for Asia-Pacific region is expected to grow at a faster rate owing to increasing prevalence of CVD diseases, growing awareness about minimally invasive surgical procedures among the healthcare infrastructure, rise in healthcare spending, and favorable government policies.  A minimally invasive surgical approach with a small incision in the chest and entering through a large artery in the chest or through the tip of the left ventricle (the apex), which is known as the transapical approach. population, improving Recent clinical trials on TAVR devices proved that these devices are non-inferior, and possibly superior, to Surgical Aortic Valve Replacement (SAVR) within the intermediate risk patient population. These trials were also noteworthy for the low complication rates observed in the TAVR groups. As TVAR’s application moves from inoperable and high risk patients to pa- tients who have moderate or lower risk for open heart surgery, the market will expand exponentially in the coming years. Companies profiled:  Edwards Lifesciences Corp.  Boston Scientific Corp.  Direct Flow medical, Inc.  Bracco SpA. Some of the key driving factors attributing to the growth of this market include increasing number of patients with cardiovascular diseases such as hyper- tension, heart failures and coronary artery diseases. In addition, increasing adoption of minimally invasive procedures over traditional surgical open heart proce- dures, reduction in hospital stays, low risk of infec- tion, minimal blood loss are further propelling the market. According to World Health Organization  JenaValve Technology, Inc.  Medtronic plc  Meril Life Sciences Pvt. Ltd.  Jude Medical, Inc.

2. To purchase complete report on Transcatheter aortic valve replacement (TAVR) Market visit: URL: https://www.infiniumglobalresearch.com/reports/transcatheter-aortic-valve-replacement- tavr-market website : www.infiniumglobalresearch.com Contact us: Email– sales@infiniumglobalresearch.com Skypeid: infiniumglobalresearch